JPY 775.0
(-0.9%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 3.78 Billion JPY | -25.48% |
2022 | 4.41 Billion JPY | 18.82% |
2021 | 4.1 Billion JPY | 29.56% |
2020 | 2.86 Billion JPY | -18.79% |
2019 | 3.98 Billion JPY | -5.13% |
2018 | 3.98 Billion JPY | 9.9% |
2017 | 3.75 Billion JPY | -7.42% |
2016 | 3.54 Billion JPY | -10.5% |
2015 | 4.55 Billion JPY | -9.64% |
2014 | 5.21 Billion JPY | -15.81% |
2013 | 6.22 Billion JPY | 28.02% |
2012 | 4.8 Billion JPY | 17.75% |
2011 | 4.09 Billion JPY | 19.94% |
2010 | 2.86 Billion JPY | 3.82% |
2009 | 3.15 Billion JPY | -23.52% |
2008 | 4.28 Billion JPY | -27.8% |
2007 | -3.68 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 675 Million JPY | 258.45% |
2024 Q2 | 1.05 Billion JPY | 56.15% |
2023 Q3 | 985 Million JPY | 17.54% |
2023 Q2 | 838 Million JPY | -25.11% |
2023 Q4 | 431 Million JPY | -56.24% |
2023 FY | - JPY | -25.48% |
2023 Q1 | 1.11 Billion JPY | 87.12% |
2022 Q3 | 1.01 Billion JPY | -15.29% |
2022 Q4 | 598 Million JPY | -41.03% |
2022 Q1 | 1.27 Billion JPY | 384.47% |
2022 Q2 | 1.19 Billion JPY | -6.41% |
2022 FY | - JPY | 18.82% |
2021 Q4 | 264 Million JPY | -78.86% |
2021 FY | - JPY | 29.56% |
2021 Q2 | 706 Million JPY | -27.66% |
2021 Q1 | 976 Million JPY | 5.97% |
2021 Q3 | 1.24 Billion JPY | 76.91% |
2020 FY | - JPY | -18.79% |
2020 Q4 | 921 Million JPY | -45.82% |
2020 Q3 | 1.7 Billion JPY | 10.82% |
2020 Q2 | 1.53 Billion JPY | 178.19% |
2020 Q1 | -1.96 Billion JPY | -408.01% |
2019 FY | - JPY | -5.13% |
2019 Q4 | 637 Million JPY | 211.17% |
2019 Q3 | -573 Million JPY | -122.28% |
2019 Q2 | 2.57 Billion JPY | 595.14% |
2019 Q1 | 370 Million JPY | -62.36% |
2018 Q2 | 927 Million JPY | 64.36% |
2018 FY | - JPY | 9.9% |
2018 Q4 | 983 Million JPY | 17.44% |
2018 Q3 | 837 Million JPY | -9.71% |
2018 Q1 | 564 Million JPY | -22.85% |
2017 Q3 | 868 Million JPY | -21.52% |
2017 FY | - JPY | -7.42% |
2017 Q2 | 1.1 Billion JPY | 6812.5% |
2017 Q1 | 16 Million JPY | -98.21% |
2017 Q4 | 731 Million JPY | -15.78% |
2016 Q2 | 1.09 Billion JPY | 112.02% |
2016 Q1 | 518.23 Million JPY | -49.82% |
2016 Q3 | 1.7 Billion JPY | 54.78% |
2016 Q4 | 894.81 Million JPY | -47.38% |
2016 FY | - JPY | -10.5% |
2015 Q1 | 1.19 Billion JPY | -42.78% |
2015 Q2 | 1.17 Billion JPY | -1.63% |
2015 FY | - JPY | -9.64% |
2015 Q3 | 1.29 Billion JPY | 10.34% |
2015 Q4 | 1.03 Billion JPY | -20.5% |
2014 Q3 | 835.12 Million JPY | -17.53% |
2014 Q2 | 1.01 Billion JPY | -20.23% |
2014 Q4 | 2.09 Billion JPY | 150.48% |
2014 Q1 | 1.26 Billion JPY | -15.37% |
2014 FY | - JPY | -15.81% |
2013 Q2 | 1.07 Billion JPY | -52.11% |
2013 Q4 | 1.49 Billion JPY | 9.37% |
2013 Q1 | 2.24 Billion JPY | 134.95% |
2013 Q3 | 1.37 Billion JPY | 27.74% |
2013 FY | - JPY | 28.02% |
2012 Q2 | 1.57 Billion JPY | 96.93% |
2012 Q3 | 1.5 Billion JPY | -4.33% |
2012 FY | - JPY | 17.75% |
2012 Q1 | 799.17 Million JPY | -19.93% |
2012 Q4 | 954.29 Million JPY | -36.62% |
2011 FY | - JPY | 19.94% |
2011 Q3 | 1.53 Billion JPY | 17.91% |
2011 Q1 | 278.02 Million JPY | -82.62% |
2011 Q2 | 1.29 Billion JPY | 366.82% |
2011 Q4 | 998.11 Million JPY | -34.78% |
2010 Q3 | 1.05 Billion JPY | 105.57% |
2010 FY | - JPY | 3.82% |
2010 Q4 | 1.59 Billion JPY | 51.51% |
2010 Q1 | 227.49 Million JPY | -82.95% |
2010 Q2 | 513.61 Million JPY | 125.78% |
2009 Q4 | 1.33 Billion JPY | 43.11% |
2009 Q1 | 347.01 Million JPY | -71.74% |
2009 FY | - JPY | -23.52% |
2009 Q3 | 932.52 Million JPY | 36.74% |
2009 Q2 | 681.99 Million JPY | 96.53% |
2008 Q2 | 1.31 Billion JPY | 0.0% |
2008 FY | - JPY | -27.8% |
2008 Q4 | 1.22 Billion JPY | 13.52% |
2008 Q3 | 1.08 Billion JPY | -18.03% |
2007 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kitanotatsujin Corporation | 1.58 Billion JPY | -138.49% |
Euglena Co., Ltd. | 676 Million JPY | -460.207% |
BEAUTY GARAGE Inc. | 1.96 Billion JPY | -92.739% |
Axas Holdings Co.,Ltd. | 555.75 Million JPY | -581.412% |
C.I. Medical Co.,Ltd. | 4.01 Billion JPY | 5.632% |
Kao Corporation | 154.49 Billion JPY | 97.549% |
Niitaka Co., Ltd. | 1.36 Billion JPY | -176.52% |
Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 92.248% |
Shiseido Company, Limited | 106.46 Billion JPY | 96.443% |
Lion Corporation | 42.31 Billion JPY | 91.05% |
Mandom Corporation | 6.69 Billion JPY | 43.469% |
Ivy Cosmetics Corporation | 242.6 Million JPY | -1461.006% |
Milbon Co., Ltd. | 7.8 Billion JPY | 51.451% |
Nippon Shikizai, Inc. | 1.28 Billion JPY | -193.89% |
Fancl Corporation | 16.6 Billion JPY | 77.191% |
KOSÉ Corporation | 26.85 Billion JPY | 85.899% |
Cota Co., Ltd. | 2.26 Billion JPY | -66.941% |
HABA Laboratories,Inc. | -1.31 Billion JPY | 388.136% |
C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -2103.704% |
Pola Orbis Holdings Inc. | 23.17 Billion JPY | 83.661% |
Noevir Holdings Co., Ltd. | 12.24 Billion JPY | 69.071% |
Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -2954.032% |
Almado, Inc. | 983.21 Million JPY | -285.164% |
I-ne CO., LTD. | 4.7 Billion JPY | 19.426% |
Premier Anti-Aging Co., Ltd. | -627 Million JPY | 703.987% |
Liberta Co.,Ltd. | 318.19 Million JPY | -1090.162% |
AXXZIA Inc. | 1.28 Billion JPY | -194.363% |
S.T. Corporation | 2.62 Billion JPY | -44.212% |
Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 88.048% |
Earth Corporation | 10.6 Billion JPY | 64.301% |
Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | -245.988% |
Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 759.778% |
Ya-Man Ltd. | 1.43 Billion JPY | -163.577% |
MTG Co., Ltd. | 4.39 Billion JPY | 13.814% |
TRANSACTION CO.,Ltd. | 5.8 Billion JPY | 34.811% |
SHOBIDO Corporation | 1.11 Billion JPY | -241.111% |
Pigeon Corporation | 15.8 Billion JPY | 76.041% |
Unicharm Corporation | 178.01 Billion JPY | 97.873% |
Paltac Corporation | 35.92 Billion JPY | 89.458% |
CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | -15.282% |